)
)
Pharming Group Investor Relations Material
Latest events
M&A Announcement
Pharming Group
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Pharming Group N.V.
Access all reports
Pharming Group N.V. is a global biopharmaceutical company based in Leiden, the Netherlands. The company specializes in the development and commercialization of protein replacement therapies and precision medicines, particularly for rare diseases. Pharming's key product is RUCONEST, a plasma-free recombinant human C1 esterase inhibitor used for treating acute hereditary angioedema (HAE). The company also has several other products in various stages of development, including treatments for Pompe and Fabry diseases and other rare disorders. The company is headquartered in Leiden, the Netherlands, and its shares are listed on both the Amsterdam Euronext and Nasdaq.
Key slides for Pharming Group N.V.
H.C. Wainwright 26th Annual Global Investment Conference 2024
Pharming Group N.V.
AGM 2024
Pharming Group N.V.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
PHARM
Country
🇳🇱 Netherlands